BioSpace News Archive

Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced the publication of its peer reviewed journal article, “Three-Year Results of the SONATA Pivotal Trial of Transcervical Fib

- Since 2011, Chevrolet has been a partner in the American Cancer Society Making Strides Against Breast Cancer movement, raising over $13.8 million to fund the future of groundbreaking breast cancer research, 24/7 support for cancer patients, and provide access to lifesaving screenings.

Genomma Lab Internacional, S.A.B. de C.V. (BMV: LABB) (“Genomma Lab” or “the Company”), today announced that it will report its Third Quarter 2020 results on Wednesday, October 21, 2020 after the Mexican Market (BMV) close. Presenters Mr. Jorge Luis Brake , Chief Executive Officer Mr. Antonio Zamora , Chief Financial Offi

Soin Neuroscience Inc. (SNI), a biotech startup based in Dayton, Ohio , has developed a novel implantable sacral nerve stimulator to treat bladder incontinence. As many as 46 million Americans 40 years of age or older have reported symptoms of urinary incontinence often due to a condition known as overactive bladder, according to th

CEO Benedikt Brueckle highlights CGM Remote Patient Monitoring in cover story for The Healthcare Insights

- Real-world study shows the effectiveness and safety of second-line Gilotrif® (afatinib) tablets following first-line immunotherapy plus chemotherapy in the treatment of squamous cell carcinoma of the lung - Separate data presented indicate afatinib activity in TKI-naïve patients with G719X/L861Q/S768I non-resistant EGFR mutation-positive NSCLC [13-October-2020]

SEngine Precision Medicine , a precision oncology company revolutionizing cancer diagnostics and drug discovery by pre-testing drugs on patient-derived tumor organoids, today announced that Chief Medical Officer Astrid L. Margossian, MD, PhD, will present at the Society for Functional Precision Medicine (SFPM) Virtual Monthly Seminar on October 14th at 11:30 am ET. Dr. Margossian is leading SEngine’s clinical validation initiatives for the PARIS ®

The U.S. Food and Drug Administration today posted five warning letters issued to companies marketing dietary supplements containing cesium chloride . In a February 2020 public health alert , the FDA warned consumers and health care professionals to avoid using dietary supplements containing cesium salts, primarily cesium c

Camargo Pharmaceutical Services, LLC, a global drug development and commercial partner, announced the appointment of Jennie Orr as Chief Strategy and Business Officer.

Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced that it has commenced an underwritten public offering of its common stock.